I only see two presentations on their website and neither of the trials involved with the presentations used 60mg. One used 40 mg on a small population (24) so I would think most would be skeptical of extrapolating data for the 40mg dose to the 60mg especially with a small n. Plus the Zytiga/Xtandi failures are with the 100mg dose. In fact if they did test the 60mg dose they didn't publish the data. The previous 60mg results (if they exist) are not even mentioned on the recent 10K. If there is anything recent that you are aware of please post it.
Market Data 
Markets 
AI
